Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
4
×
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
investing
nonalcoholic steatohepatitis
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
aquestive therapeutics
arch venture partners
arimoclomol
What
cancer
4
×
roundup
bio
amid
bombast
cash
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
ahead
ambien
american
annual
appetite
asco
attendees
attention
biotech
black
bread
butter
buyout
camp’s
chicago
city
clinical
combinations
Language
unset
Current search:
startups
×
" san francisco blog main "
×
" texas blog main "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More